Solid Tumors
Showing 9951 - 9975 of >10,000
Colorectal Cancer Metastatic Trial (radioembolization, Standard of care first-line systemic therapy)
Not yet recruiting
- Colorectal Cancer Metastatic
- radioembolization
- Standard of care first-line systemic therapy
- (no location specified)
Oct 26, 2021
Triple-negative Breast Cancers in Order to Validate Interest of
Not yet recruiting
- Triple Negative Breast Cancer
- Organoid
- Establishment of ex vivo breast cancer organoid models
-
Caen, FranceCentre François Baclesse
Aug 9, 2022
Human Papillomavirus Infection in Paediatric Kidney and Liver
Recruiting
- Paediatric Kidney or Liver Transplantation
- Chronic Kidney Disease
-
Heidelberg, GermanyUniversity Children's Hospital
May 31, 2021
Voiding Disorders in Children After Sacrococcygeal Teratoma
Completed
- Sacrococcygeal Teratoma
- +2 more
-
Montpellier, FranceUniversity hospital of Montpellier
Jan 10, 2022
Pancreatic Cancer, Periampullary Cancer Trial in Nijmegen (USPIO-enhanced MRI)
Terminated
- Pancreatic Cancer
- Periampullary Cancer
- USPIO-enhanced MRI
-
Nijmegen, NetherlandsRadboudumc
Sep 19, 2021
Pilomyxoid Astrocytoma, Pilocytic Astrocytoma, Glioma, Astrocytic Trial in New Hyde Park (Mebendazole, Vincristine, Carboplatin)
Recruiting
- Pilomyxoid Astrocytoma
- +11 more
- Mebendazole
- +5 more
-
New Hyde Park, New YorkCohen Children's Medical Center of New York
Mar 3, 2021
Pancreatic Tumor Trial in Monterrey (Endoscopic ultrasound-guided biopsy)
Recruiting
- Pancreatic Neoplasm
- Endoscopic ultrasound-guided biopsy
-
Monterrey, Nuevo León, MexicoHéctor Miguel Delgado Cortes
Apr 11, 2021
Protein P16 Expression in Ovarian Germ Cell Tumors.
Completed
- Ovarian Neoplasms
- +2 more
- p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267)
- Ki67 antibody (DAKO) for malignant cases only
-
Assiut, EgyptAssiut University
Aug 12, 2021
Hepatocellular Carcinoma, Hepatitis b Virus, Radiotherapy Trial
Not yet recruiting
- Hepatocellular Carcinoma
- +3 more
- (no location specified)
Feb 21, 2023
NK Cell Mediated Immunity Trial in Shenzhen (NK cells)
Unknown status
- NK Cell Mediated Immunity
- NK cells
-
Shenzhen, Guangdong, ChinaShenzhen Luohu Hospital
Dec 4, 2019
Malignant Melanoma Trial in France (Cobimetinib + Vemurafenib combination treatment)
Completed
- Malignant Melanoma
- Cobimetinib + Vemurafenib combination treatment
-
Bordeaux, France
- +16 more
Jan 23, 2020
Gastroesophageal Junction Adenocarcinoma, Stomach Adenocarcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma Trial in
Unknown status
- Gastroesophageal Junction Adenocarcinoma
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Feb 8, 2020
Cancer of Rectum, Cancer of the Rectum, Tumor, Rectum Trial in Saint Louis (Radiation, Oxaliplatin, Leucovorin)
Completed
- Cancer of Rectum
- +6 more
- Radiation
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 10, 2021
Breast Cancer Trial in Houston (Dasatinib, AZD6244)
Terminated
- Breast Cancer
-
Houston, TexasUT MD Anderson Cancer Center
Sep 1, 2020
Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma Ureter Trial in Dallas (sterile water irrigation, Gemcitabine)
Recruiting
- Urothelial Cancer of Renal Pelvis
- Urothelial Carcinoma Ureter
- sterile water irrigation
- Gemcitabine
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Nov 30, 2021
Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin,
Completed
- Well-differentiated Non-functional NET of Thoracic Origin
- +3 more
-
Duarte, California
- +34 more
Mar 16, 2021
Squamous NSCLC Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody,
Completed
- Squamous Non-Small Cell Lung Cancer
- Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody
- +3 more
-
Chandler, Arizona
- +241 more
Mar 17, 2022
Adrenal Incidentaloma, Adrenocortical Carcinoma Trial in Groningen
Recruiting
- Adrenal Incidentaloma
- Adrenocortical Carcinoma
-
Groningen, NetherlandsUniversity Medical Center Groningen
Sep 29, 2021
Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)
Active, not recruiting
- Malignant Peripheral Nerve Sheath Tumors
- Neurofibromatosis 1
-
Washington, District of Columbia
- +4 more
Apr 1, 2022
Small Cell Carcinoma Trial in Seattle (Nortriptyline Hydrochloride, Paclitaxel)
Completed
- Small Cell Carcinoma
- Nortriptyline Hydrochloride
- Paclitaxel
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 16, 2019